文献速递免疫规划

共施用表达GM-CSF的RNA增强SAM疫苗效力

Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines.
PubMed 文献 · Vaccine · 2019-06-18

本研究在小鼠中评估共施用表达鼠源GM-CSF的SAM载体(SAM-GM-CSF)与编码流感病毒核蛋白的SAM疫苗(SAM-NP)能否增强免疫应答。结果显示,SAM-GM-CSF可增加注射部位抗原提呈细胞募集,并显著提高NP特异性CD8+ T细胞应答的频率与体内功能活性,同时增强对致死性流感病毒攻击的保护。结论认为,增加注射部位APC募集与SAM疫苗接种效力增强相关,可能成为增强RNA疫苗效力的有力工具。

要点

  • SAM-GM-CSF共施用可增强注射部位抗原提呈细胞募集。
  • 共施用SAM-GM-CSF与SAM-NP可提高NP特异性CD8+ T细胞应答频率及体内功能活性。
  • 共免疫可增强对致死性流感病毒攻击的保护。

核心结论

  • 增加注射部位抗原提呈细胞募集与SAM疫苗接种效力增强相关,可能成为增强RNA疫苗效力的有力工具。

研究设计与样本

  • 在小鼠中研究单次免疫SAM疫苗时,通过增加注射部位APC募集来增强免疫应答的可能性。
  • 选择鼠源粒细胞-巨噬细胞集落刺激因子(GM-CSF)作为APC的模型趋化因子,构建SAM-GM-CSF载体。
  • 评估SAM-GM-CSF与编码流感A病毒核蛋白(NP)的SAM构建体联用是否增加APC募集和NP特异性免疫应答。

主要发现

  • 施用SAM-GM-CSF可增强注射部位APC的募集。
  • 共施用SAM-GM-CSF与SAM-NP可显著提高NP特异性CD8+ T细胞应答的幅度,包括细胞毒性抗原特异性CD8+ T细胞频率及其体内功能活性。
  • 共免疫SAM-GM-CSF与SAM-NP可增加对致死性流感病毒攻击的保护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Self-amplifying mRNAs (SAM)-based vaccines have been shown to induce a robust immune response in various animal species against both viral and bacterial pathogens. Due to their synthetic nature and to the versatility of the manufacturing process, SAM technology may represent an attractive solution for rapidly producing novel vaccines, which is particularly critical in case of pandemic infections or diseases mediated by newly emerging pathogens. Recent published data support the hypothesis that Antigen Presenting Cells (APCs) are responsible for CD8+ T-cell priming after SAM vaccination, suggesting cross-priming as the key mechanism for antigen presentation by SAM vaccines. In our study we investigated the possibility to enhance the immune response induced in mice by a single immunization with SAM by increasing the recruitment of APCs at the site of injection. To enhance SAM immunogenicity, we selected murine granulocyte-macrophage colony-stimulating factor (GM-CSF) as a model chemoattractant for APCs, and developed a SAM-GM-CSF vector. We evaluated whether the use of SAM-GM-CSF in combination with a SAM construct encoding the Influenza A virus nucleoprotein (NP) would lead to an increase of APC recruitment and NP-specific immune response. We indeed observed that the administration of SAM-GM-CSF enhances the recruitment of APCs at the injection site. Consistently with our hypothesis, co-administration of SAM-GM-CSF with SAM-NP significantly improved the magnitude of NP-specific CD8+ T-cell response both in terms of frequency of cytotoxic antigen-specific CD8+ T-cells and their functional activity in vivo. Furthermore, co-immunization with SAM-GM-CSF and SAM-NP provided an increase in protection against a lethal challenge with influenza virus. In conclusion, we demonstrated that increased recruitment of APCs at the site of injection is associated with an enhanced effectiveness of SAM vaccination and might be a powerful tool to potentiate the efficacy of RNA vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Manara C, Brazzoli M, Piccioli D, et al. Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines. Vaccine. 2019. PMID: 31227353. doi:10.1016/j.vaccine.2019.04.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。